Foreign Secretary Harsh Vardhan Shringla said that India is looking to collaborate with Russia to manufacture a large amount of Sputnik V vaccine.
He said, "Sputnik V vaccine is in phase 3 trial in India and we expect this to be completed by mid-March, after which our regulator will look at emergency use authorization.
We're looking to collaborate with Russia to manufacture a large amount of Sputnik V vaccine."